Study title: A Phase III, Prospective, Placebo-Controlled, Double-Blinded, Randomized, Multi-Center Study to Determine the Safety and Efficacy of Calcijex® (Calcitriol Injection) in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric End Stage Renal Disease Patients on Hemodialysis
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CALCITRIOL | |||||
| ATC code: | |||||
| Document link: Calcitriol-1999007.pdf | |||||
| Document date: 2011-09-13 | |||||
| Study number: 1999007 | |||||
| EudraCT number: | |||||
| Scope of study: | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |